secwatch / observer
8-K filed May 15, 2023, 7:59 PM ET ticker KITT CIK 0001849820
earnings confidence high sentiment negative materiality 0.70

Nauticus Robotics Q1 2023 revenue $2.8M (+26% YoY), net loss widens to $10.2M

Nauticus Robotics, Inc.

2023-Q1 EPS reported -$0.26 vs consensus -$0.14 ▼ miss (-82.1%)

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Nauticus Robotics, Inc. reported the first quarter ended March 31, 2023 results: revenue $2.8 million, net income $10.2 million, EPS $0.26 per basic and diluted share.

Period
the first quarter ended March 31, 2023
Revenue
$2.8 million
Net income
$10.2 million
EPS
$0.26 per basic and diluted share
Result
reported results
Exact text from the filing
First Quarter 2023 Financial Results Nauticus reported first quarter revenue of $2.8 million compared to $2.2 million in the prior-year period. The increase in revenue is primarily attributable to one new contract and the continuation and increased performance on existing service contracts from the prior year. Total operating expenses during the first quarter were $8.6 million, a $3.7 million increase from the prior-year period. The increase was mainly attributable to higher cost of revenue and increased general and administrative (“G&A”) costs associated with being a public company. For the quarter, Nauticus recorded a net loss attributable to common stockholders of $10.2 million, or $0.26 per basic and diluted share. This compares to a net loss attributable to common stockholders of $3.5 million, or $0.36 per basic and diluted share in the prior year comparable period.
View on SEC.gov

Browse all earnings releases →

Nauticus Robotics, Inc. filing history →

Source: SEC EDGAR
accession 0001213900-23-039933
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.